The partnering scope ranges from innovative to generic, from early stage candidates to approved, prescription or OTC drugs, medical devices and companion diagnostics. Delegates determine the focus, displayed and updated hourly on Internet as soon as sufficient data are submitted.
Info: RauCon, Dr. Norbert Rau
eMail: meetyou@europlx.com